The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The myth of the biotech revolution
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wilkinson, R. G. (2002) · Routledge eBooks · doi:10.4324/9780203421680 · Cited by 1,437
(1990) · American Economic Review · Cited by 1,345
New Goals for the U.S. Human Genome Project: 1998-2003
Collins, F. S., Patrinos, A., Jordan, E., Chakravarti, A., Gesteland, R., Walters, L., & groups, T. M. O. T. D. A. N. P. (1998) · Science · doi:10.1126/science.282.5389.682 · Cited by 854
Biology as Ideology: The Doctrine of DNA
Lewontin, R. C. (1991) · DigitalGeorgetown (Georgetown University Library) · Cited by 619
Biology as Ideology: The Doctrine of DNA
Lewontin, R. C. (1991) · Cited by 511
Drug research: myths, hype and reality
Kubinyi, H. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1156 · Cited by 348
The Drugs Don't Work: Expectations and the Shaping of Pharmacogenetics
Hedgecoe, A., & Martin, P. (2003) · Social Studies of Science · doi:10.1177/03063127030333002 · Cited by 340
Self-citationHorrobin, D. F. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1012 · Cited by 248
The new genetics: The new genetics in clinical practice
Bell, J. (1998) · BMJ · doi:10.1136/bmj.316.7131.618 · Cited by 214
Economies of scale in experimentation: knowledge and technology in pharmaceutical R&D
Nightingale, P. (2000) · Industrial and Corporate Change · doi:10.1093/icc/9.2.315 · Cited by 201
Self-citationTechnology policy and the regions — the case of the BioRegio contest
Dohse, D. (2000) · Research Policy · doi:10.1016/s0048-7333(99)00077-3 · Cited by 191
Strategic trends in the drug industry
Drews, J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02690-4 · Cited by 165
Giesecke, S. (2000) · Research Policy · doi:10.1016/s0048-7333(99)00061-x · Cited by 150
Nature, nurture and human disease
Chakravarti, A., & Little, P. (2003) · Nature · doi:10.1038/nature01401 · Cited by 148
Economies of Scale in Experimentation: Knowledge and Technology in Pharmaceutical R&D
Ightingale, P. A. N. (2000) · Cited by 120
Technological interdependence in the American economy
Rosenberg, N. (1983) · Cambridge University Press eBooks · doi:10.1017/cbo9780511611940.004 · Cited by 110
Technological Interdependence in the American Economy
Rosenberg, N. (1979) · Technology and Culture · doi:10.2307/3103110 · Cited by 109
Realism in drug discovery—could Cassandra be right?
Horrobin, D. F. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1099 · Cited by 79
Zacharias, J. F. (1990) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1111/j.1552-6909.1990.tb01630.x · Cited by 78
Transforming Life, Transforming Business: The Life Science Revolution
Enriquez, J., & Goldberg, R. A. (2000) · Cited by 54
Williams, M. J. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.06.001 · Cited by 43
The double helix in clinical practice
Bell, J. I. (2003) · Nature · doi:10.1038/nature01402 · Cited by 42
Medicines in the 21st century Or pills, politics, potions, and profits: Where is public policy?
Triggle, D. J. (2003) · Drug Development Research · doi:10.1002/ddr.10282 · Cited by 24
Cited by
Green Grabbing: a new appropriation of nature?
Fairhead, J., Leach, M., & Scoones, I. (2012) · The Journal of Peasant Studies · doi:10.1080/03066150.2012.671770 · Cited by 1,928
Assetization: Turning Things into Assets in Technoscientific Capitalism
(2020) · The MIT Press eBooks · doi:10.7551/mitpress/12075.001.0001 · Cited by 421
The pharmaceuticalisation of society? A framework for analysis
Williams, S. J., Martin, P., & Gabe, J. (2011) · Sociology of Health & Illness · doi:10.1111/j.1467-9566.2011.01320.x · Cited by 396
Self-citationTheorizing the Bioeconomy: Biovalue, Biocapital, Bioeconomics or . . . What?
Birch, K., & Tyfield, D. (2013) · Science, Technology, & Human Values · doi:10.1177/0162243912442398 · Cited by 355
Rethinking Value in the Bio-economy: Finance, Assetization, and the Management of Value
Birch, K. (2017) · Science, Technology, & Human Values · doi:10.1177/0162243916661633 · Cited by 346
Metadata
- Authors
- Nightingale, P., & Martin, P.
- Venue
- Trends in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 22
- Issue
- 11
- Pages
- 564-569
- ISSN
- 0167-7799 (ISSN-L)
- OpenAlex
- W2155253059
- Cited by
- 259
- References
- 23
- FWCI
- 12.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.